VPAG

News

UK follows through on doubling of statutory scheme rate

UK pharma firms have reacted angrily to the news that the government has doubled the statutory scheme rebate on the sales of newer drugs to the NHS.

Market Access

Medicines pricing, UK £20 notes with various pills

Buyer’s remorse: The UK’s VPAG

With the ABPI wanting to change the scheme just over a year into its five-year term, it seems that they have buyer’s remorse.

News

UK is becoming an 'outlier' for pharma, hitting investment

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

Market Access

blue and white medication capsule tablets

NHS medicines spending in England in greater focus

Leela Barham provides a perspective on the ABPI blog that covers understanding NHS medicines spending in England.

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

UK follows through on doubling of statutory scheme rate

Buyer’s remorse: The UK’s VPAG

UK is becoming an 'outlier' for pharma, hitting investment

NHS medicines spending in England in greater focus

Pharma furious as UK Statutory Scheme rebate rate soars

Pharma urges NHS to put medicines at heart of 10-year plan

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

VPAG

Editor's Picks